Ez Clinical Laboratory INC

Ez Clinical Laboratory INC was paid $880K by Medicaid between Jan 2018 and Feb 2024, across 29 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 79% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#67 of 122

Median peer was paid$1.29M

This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,418	$246.73
2019	1,062	$173.67
2020	5,646	$132K
2021	15,703	$472K
2022	9,793	$262K
2023	7,216	$14K
2024incomplete	645	$197.08

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	79%	9,910	8,801	$695K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	14%	5,625	5,004	$126K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	5.9%	3,607	3,325	$52K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	120	117	$5K
82607		<1%	965	816	$1K
82746		<1%	748	641	$741.30
80061	Lipid panel	<1%	1,882	1,823	$288.87
80053	Comprehensive metabolic panel	<1%	2,785	2,641	$273.64
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	879	789	$151.34
82728		<1%	817	754	$149.82
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	2,756	2,603	$143.21
86141		<1%	156	73	$90.65

17 more codes

84443	Thyroid stimulating hormone (TSH)	<1%	1,241	$77.39
36415	Collection of venous blood by venipuncture	<1%	3,297	$55.12
83036	Hemoglobin; glycosylated (A1C)	<1%	1,684	$52.80
84153		<1%	153	$48.99
83550		<1%	793	$46.20
83540		<1%	802	$27.00
85045		<1%	510	$18.99
81001		<1%	1,257	$11.80
82043		<1%	562	$4.30
82570		<1%	114	$3.00
84550		0%	375	$0.00
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	0%	133	$0.00
84439		0%	13	$0.00
85610		0%	14	$0.00
85651		0%	189	$0.00
87086	Culture, bacterial; quantitative colony count, urine	0%	59	$0.00
86140		0%	37	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOHAMED, SHERIF (PRESIDENT)